Switching from Prolia to Oral Bisphosphonates: What You Need to Know

Many women and men with osteoporosis are treated with Prolia (denosumab), an injection given every six months. It is a powerful medication that helps strengthen bones and reduce fracture risk. But what happens if you need to stop Prolia? This is an important question, because stopping suddenly can put your bones at risk.

Why Stopping Prolia under careful clinician oversight Matters

Prolia works by turning down the activity of cells that break down bone. When it wears off, those cells rebound very quickly. Without another treatment in place, this can lead to rapid bone loss and a much higher risk of fractures, especially in the spine. These rebound fractures often happen within months of the last injection.

The Role of Bisphosphonates

Bisphosphonates, such as alendronate (Fosamax) or risedronate (Actonel), are tablets that also slow bone breakdown. They are not quite as strong as Prolia, but they are very effective at maintaining bone strength. If Prolia is stopped, switching to a bisphosphonate helps prevent the dangerous rebound effect.

What the Guidelines Say

Several expert groups around the world have given clear advice:

• Endocrine Society (2019): Do not stop Prolia without follow-up therapy. Begin an antiresorptive drug, such as a bisphosphonate, around the time the next injection would have been due.

• European Calcified Tissue Society (2020): Recommends intravenous zoledronic acid as the first choice, given six months after the last Prolia dose. Oral bisphosphonates are acceptable alternatives.

• American Association of Clinical Endocrinology (2020): Strongly advises against drug holidays with Prolia. Always switch to another bone-protecting treatment.

• National Osteoporosis Guideline Group UK (2024): If Prolia is stopped, start a bisphosphonate at the time the next injection was due to reduce fracture risk.

The message is the same across all guidelines: never stop Prolia without a plan in place.

How the Switch Is Done

• Timing: Start the bisphosphonate when your next Prolia injection would have been due (usually six months after the last dose).

• Choice of drug: Alendronate (weekly) or risedronate (weekly or monthly) are the common oral options. Zoledronic acid as a yearly infusion may be used if tablets are not suitable.

• Preparation: Make sure your calcium and vitamin D levels are healthy before starting. You also need to be able to sit upright after taking the tablets, as this protects your oesophagus.

• Duration: Most people will need at least one to two years of bisphosphonate therapy to cover the rebound period.

Take-Home Message

If you are thinking about stopping Prolia, do not do it on your own. Always speak to your doctor about the safest way to transition. Switching to an oral bisphosphonate is not only possible, it is essential for protecting your bones from sudden weakness and fractures. With the right plan, you can make the switch safely and continue to keep your bones strong.